0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Clinical Challenge | 
Wenyu Huang, MD, PhD; Rukhsana G. Mirza, MD; Mark E. Molitch, MD
JAMA. 2015;314(23):2555-2556. doi:10.1001/jama.2015.9162.

Editorial | 
Timothy W. Olsen, MD
JAMA. 2015;314(20):2135-2136. doi:10.1001/jama.2015.15409.

Original Investigation | 
Writing Committee for the Diabetic Retinopathy Clinical Research Network
JAMA. 2015;314(20):2137-2146. doi:10.1001/jama.2015.15217.
Includes: CME, Supplemental Content

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2015;314(20):2184-2185. doi:10.1001/jama.2015.15427.

From the JAMA Network | 
Sandeep Vijan, MD, MS; Angela Fagerlin, PhD
JAMA. 2015;314(17):1861-1862. doi:10.1001/jama.2015.11518.

From the JAMA Network | 
Kurt Kroenke, MD
JAMA. 2015;313(16):1666-1667. doi:10.1001/jama.2015.107.

Editorial | 
Bryan Williams, MD
JAMA. 2015;313(6):573-574. doi:10.1001/jama.2015.89.

Original Investigation |  FREE
Connor A. Emdin, HBSc; Kazem Rahimi, DM, MSc; Bruce Neal, PhD; et al.
JAMA. 2015;313(6):603-615. doi:10.1001/jama.2014.18574.
Includes: CME, Supplemental Content

Viewpoint | 
Lee M. Jampol, MD; Neil M. Bressler, MD; Adam R. Glassman, MS
JAMA. 2014;311(22):2269-2270. doi:10.1001/jama.2014.2536.

Editorial | 
David C. Musch, PhD, MPH; Thomas W. Gardner, MD, MS
JAMA. 2012;308(22):2403-2404. doi:10.1001/jama.2012.114286.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Original Investigation  | 
Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort
Writing Team for the DCCT/EDIC Research Group
JAMA Ophthalmology
Original Investigation  | 
Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving in Patients With Diabetic Macular Edema Report From RESTORE, RIDE, and RISE Trials
Neil M. Bressler, MD; Rohit Varma, MD; Paul Mitchell, MD; et al.
JAMA Ophthalmology
Invited Commentary  | 
Drilling Deeper for Treatment Choices in Diabetic Macular Edema
Emily Y. Chew, MD
JAMA Ophthalmology
Original Investigation  | 
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
John A. Wells, MD; Adam R. Glassman, MS; Lee M. Jampol, MD; et al.